Literature DB >> 12605905

Sleep modulates cannabinoid receptor 1 expression in the pons of rats.

M Martínez-Vargas1, E Murillo-Rodríguez, R González-Rivera, A Landa, M Méndez-Díaz, O Prospro-García, L Navarro.   

Abstract

Endocannabinoids seem to play a role in the modulation of alertness. Therefore, we measured cannabinoid receptor 1 (CB1R) protein by Western blot and messenger RNA (mRNA) by reverse transcription-polymerase chain reaction in the pons of rats across the 24-h period. We performed evaluations every 4 h beginning at 09:00 h. Rats were under a controlled light/dark cycle 12:12 (lights on at 08:00 h). Our data suggest that the expression of CB1R gene depends on diurnal variations, with maximum expression at 13:00 h for protein and 21:00 h for mRNA, and minimum expression at 01:00 and 09:00 h, respectively. We also analyzed CB1R protein and mRNA levels in the pons of rats deprived of total sleep for 24 h and in rats with a 24-h period of sleep deprivation plus a 2-h period of sleep rebound. Unlike sleep deprivation, sleep rebound significantly increased CB1R protein while decreasing mRNA. Despite the fact that we used gentle manipulation to deprive the animals of sleep, there may be a potential influence of stress on this effect, too. However, these facts suggest that CB1R gene expression is modulated by the light/dark cycle and by sleep.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605905     DOI: 10.1016/s0306-4522(02)00820-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol.

Authors:  E C Hanlon; E Tasali; R Leproult; K L Stuhr; E Doncheck; H de Wit; C J Hillard; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

2.  Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability.

Authors:  Cleo L Crunelle; Elsmarieke van de Giessen; Sybille Schulz; Louk J M J Vanderschuren; Kora de Bruin; Wim van den Brink; Jan Booij
Journal:  Addict Biol       Date:  2011-09-29       Impact factor: 4.280

Review 3.  Neuronal activity: from in vitro preparation to behaving animals.

Authors:  François Windels
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

4.  Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).

Authors:  Erin C Hanlon
Journal:  Psychoneuroendocrinology       Date:  2019-10-04       Impact factor: 4.905

5.  Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.

Authors:  John D Douglass; Yin Xiu Zhou; Amy Wu; John A Zadroga; Angela M Gajda; Atreju I Lackey; Wensheng Lang; Kristen M Chevalier; Steven W Sutton; Sui-Po Zhang; Christopher M Flores; Margery A Connelly; Judith Storch
Journal:  J Lipid Res       Date:  2015-04-04       Impact factor: 5.922

Review 6.  Endocannabinoid signalling: has it got rhythm?

Authors:  Linda K Vaughn; Gerene Denning; Kara L Stuhr; Harriet de Wit; Matthew N Hill; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 7.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

8.  The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Authors:  Sachin Patel; Eric R Wohlfeil; David J Rademacher; Erica J Carrier; LaToya J Perry; Abhijit Kundu; J R Falck; Kasem Nithipatikom; William B Campbell; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  A potential function of endocannabinoids in the selection of a navigation strategy by rats.

Authors:  Pavel E Rueda-Orozco; Edgar Soria-Gomez; Corinne J Montes-Rodriguez; Marina Martínez-Vargas; Oscar Galicia; Luz Navarro; Oscar Prospero-García
Journal:  Psychopharmacology (Berl)       Date:  2007-09-06       Impact factor: 4.530

10.  Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid.

Authors:  Dagmar Koethe; Daniela Schreiber; Andrea Giuffrida; Christian Mauss; Johannes Faulhaber; Bernd Heydenreich; Martin Hellmich; Rudolf Graf; Joachim Klosterkötter; Daniele Piomelli; F Markus Leweke
Journal:  J Neural Transm (Vienna)       Date:  2009-01-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.